Results 191 to 200 of about 1,914,765 (303)

The Mediating Role of Illness Perception Between Psychological Capital and Subjective Well-Being in Breast Cancer Patients: A Cross-Sectional Study. [PDF]

Curr Oncol
Liu M, Zhang Y, Xu C, Liu Y, Wang Y, Wang Y, Wang Z, Hong J.   +7 more
europepmc   +1 more source

Strategic Shift: The Power of Green Strategy on Sustainability Performance

Business Strategy and the Environment, EarlyView.
ABSTRACT Employing FTSE Russell's unique Green Revenues data on S&P 1500 firms from 2016 to 2024, this study examines the long‐term effects of a corporate strategic shift toward green strategy, proxied by green revenue reporting, on corporate sustainability performance.
Post Raj Pokharel
wiley   +1 more source

A cost-based-plus pricing approach for repurposed tiratricol in the treatment of Allan-Herndon-Dudley syndrome. [PDF]

Orphanet J Rare Dis
Manders E, Keestra S, Bannenberg W, van der Wel V, de Visser S, Hollak C.   +5 more
europepmc   +1 more source

Board Networks and Corporate Carbon Emissions: A Cross‐Country Analysis of Causal Effects

Business Strategy and the Environment, EarlyView.
ABSTRACT This study examines whether board networks influence corporate carbon emissions and the strategic pathways through which firms decarbonize. Using a sample of 1952 firms across 48 countries from 2003 to 2020, we employ dynamic stacked regressions that exploit exogenous carbon‐regulation shocks affecting firms connected through shared third ...
Katarzyna Burzynska, Sara Jonsson, Lu Liu, Michał Dzieliński   +3 more
wiley   +1 more source

The Case for Standardized Normalization of Tear Fluid Proteomics. [PDF]

Ophthalmol Sci
Sharma A, Sharma S, Asbell PA.
europepmc   +1 more source

Advancing Theory and Practice Concerning CO2e Emissions: A Time‐Based Tool for Organisations

Business Strategy and the Environment, EarlyView.
ABSTRACT Although organisations are increasingly scrutinised on their CO2e emissions, economic growth is frequently encouraged. Eco‐efficiency–based initiatives—‘doing more with less’—could be a solution. The problem is that many organisations (e.g., smaller enterprises without access to specialist knowledge) have difficulties in gauging the impact of ...
Andrea Stevenson Thorpe, Frank Figge
wiley   +1 more source

Repurposing biosimilars, rethinking costs: a framework for sustainable drug pricing for repurposed bevacizumab for intravitreal injections. [PDF]

Eur J Health Econ
Manders EA, van Der Wel V, Schlingemann R, Hollak CEM, de Visser SJ.   +4 more
europepmc   +1 more source

Capitalizing vs expensing R & D and stock price informativeness

, 2012
This project is a study of R&D treatment in UK companies before and after the adaptation of IFRS. It is held in the thesis for the Master's Division of Banking and Financial Management at the University of Piraeus. We use very recent data from UK companies that engage R&D activities and two different periods and respond to these calls for research.
openaire   +1 more source

ESG Controversies in Global Firms: A Black Mark?

Business Strategy and the Environment, EarlyView.
ABSTRACT Despite increasing attention paid by companies to sustainability, there is still evidence of environmental, social and governance (commonly referred to as ESG) scandals. As research on this topic is scant, this paper aims to analyse the impact of ESG controversies on firms' sustainability practices, that is, ESG policies, as well as ...
Beatrice Bais, Guido Orzes, Marco Sartor
wiley   +1 more source

Reply to: In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid Tumors. [PDF]

J Clin Oncol
Ratan R, Kasper B, Alcindor T, Schöffski P, van der Graaf WT, Federman N, Bui NQ, D'Amato G, Riedel RF, Attia S, Chawla S, Lim A, Tumminello B, Oton AB, Chu Y, Zhou S, Gounder M.   +16 more
europepmc   +1 more source